Review:
Who Pharmacovigilance Reports
overall review score: 4.3
⭐⭐⭐⭐⭐
score is between 0 and 5
WHO Pharmacovigilance Reports are systematic collections of safety data related to medicinal products, issued by the World Health Organization to monitor and analyze adverse drug reactions worldwide. These reports aim to ensure drug safety, identify potential risks, and support regulatory decisions to protect public health.
Key Features
- Global surveillance of adverse drug reactions
- Standardized reporting formats for consistency
- Regular publication of safety updates and risk assessments
- Collaborative data collection from multiple countries
- Supports regulatory actions and policy making
- Accessible through WHO databases and publications
Pros
- Enhances global drug safety monitoring
- Facilitates early detection of adverse effects
- Promotes international cooperation in pharmacovigilance
- Provides valuable information for healthcare professionals
- Contributes to evidence-based medication use
Cons
- Reports may sometimes be delayed due to data collection processes
- Data quality can vary across different reporting regions
- Complexity of interpreting large datasets for non-experts
- Limited accessibility outside professional or regulatory contexts